Saturday, June 30, 2007

FDA requests label change regarding Risperdal and diabetes

FDA Requests Label Change Regarding Risperdal and Diabetes. In 2003, the US Food and Drug Administration sent a letter to the manufacturer requesting additional information be placed on the Risperdal label, warning about a possible Risperdal-diabetes link. A similar request was made to five other manufacturers of new antipsychotic medications. Continued...

1 comments:

TV Digital said...

Hello. This post is likeable, and your blog is very interesting, congratulations :-). I will add in my blogroll =). If possible gives a last there on my blog, it is about the TV Digital, I hope you enjoy. The address is http://tv-digital-brasil.blogspot.com. A hug.